In particular, in a rat model of short bowel syndrome, systemic infusion of leptin was found to enhance small intestine carbohydrate absorption and GLUT5 gene expression beyond the normal adaptive response (Pearson et al. 2001). The gene discussed is SLC2A5; the disease is short bowel syndrome.